We've found
184,457
clinical trials
Children Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy Trial Clinical Trial
A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hematology Clinical Trial
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
Status: Enrolling,
Phase
Updated: 6/18/2010
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Longitudinal Study of Mitochondrial Hepatopathies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Longitudinal Study of Mitochondrial Hepatopathies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 11/10/2011
Click here to add this to my saved trials
Reproductive Clinical Trial
A Prospective Natural History Study of Patients With Syringomyelia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Hereditary Hemorrhagic Telangiectasia Clinical Trial
Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hereditary Hemorrhagic Telangiectasia Clinical Trial
Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
131-I-MIBG Therapy for Refractory Neuroblastoma and Metastatic Paraganglioma/Pheochromocytoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Sinusitis Clinical Trial
Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children
Status: Enrolling
Updated: 2/26/2016
Click here to add this to my saved trials
Inflammatory Bowel Disease Clinical Trial
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Inflammatory Bowel Disease Clinical Trial
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Oncology Clinical Trial
Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Status: Enrolling,
Phase
II
Updated: 11/30/2012
Click here to add this to my saved trials
Leukemia Clinical Trial
Collection of Blood and/or Bone Marrow for Investigation and Characterization of Normal and Abnormal Cell Growth
Status: Enrolling,
Phase
Updated: 3/27/2018
Click here to add this to my saved trials
Liver Neoplasms Clinical Trial
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Status: Enrolling
Updated: 11/29/2012
Click here to add this to my saved trials
Aging Clinical Trial
Oxidative Stress Links Aging, Activity and Mobility Limitation
Status: Enrolling,
Phase
I
Updated: 1/28/2016
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Click here to add this to my saved trials
Hematology Clinical Trial
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
The OMEGA Clinical Trial
Status: Enrolling
Updated: 7/31/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
The OMEGA Clinical Trial
Status: Enrolling
Updated: 7/31/2012
Click here to add this to my saved trials
Gastroenterology, Other, Reproductive Clinical Trial
Effect of Vitamin D Supplementation on In-vitro Fertilization (IVF) Outcomes
Status: Enrolling,
Phase
II
Updated: 7/24/2013
Click here to add this to my saved trials
Tetralogy of Fallot Clinical Trial
Assessment of Right Ventricular Volume in Tetralogy of Fallott (TOF) Patients
Status: Enrolling
Updated: 10/5/2012
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant
Status: Enrolling
Updated: 8/26/2013
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 11/3/2014
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 11/3/2014
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 11/3/2014
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 11/3/2014
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 11/3/2014
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 11/3/2014
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/22/2013
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/22/2013
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Effect of Metformin on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
Status: Enrolling
Updated: 1/19/2018
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
Status: Enrolling
Updated: 1/19/2018
Click here to add this to my saved trials
Infection Clinical Trial
Antibiotic Prophylaxis Before Percutaneous Gastrostomy
Status: Enrolling
Updated: 12/3/2015
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Brain Circuits in Schizophrenia and Smoking
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Rheumatology Clinical Trial
The Pathogenesis and Natural History of Sjogren s Syndrome
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)
Status: Enrolling,
Phase
III
Updated: 12/16/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)
Status: Enrolling,
Phase
III
Updated: 12/16/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)
Status: Enrolling,
Phase
III
Updated: 12/16/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)
Status: Enrolling,
Phase
III
Updated: 12/16/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)
Status: Enrolling,
Phase
III
Updated: 12/16/2015
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate
Status: Enrolling
Updated: 7/1/2013
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling,
Phase
II
Updated: 12/2/2013
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling,
Phase
II
Updated: 12/2/2013
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling,
Phase
II
Updated: 12/2/2013
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling,
Phase
II
Updated: 12/2/2013
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling,
Phase
II
Updated: 12/2/2013
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Status: Enrolling,
Phase
III
Updated: 12/9/2014
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Status: Enrolling,
Phase
III
Updated: 12/9/2014
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Status: Enrolling,
Phase
III
Updated: 12/9/2014
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Status: Enrolling,
Phase
III
Updated: 12/9/2014
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Status: Enrolling,
Phase
III
Updated: 12/9/2014
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Status: Enrolling,
Phase
III
Updated: 12/9/2014
Click here to add this to my saved trials
Ischemic Stroke Clinical Trial
Assess the Penumbra System in the Treatment of Acute Stroke
Status: Enrolling,
Phase
IV
Updated: 2/19/2014
Click here to add this to my saved trials
Ischemic Stroke Clinical Trial
Assess the Penumbra System in the Treatment of Acute Stroke
Status: Enrolling,
Phase
IV
Updated: 2/19/2014
Click here to add this to my saved trials
Other Clinical Trial
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Other Clinical Trial
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Other Clinical Trial
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Other Clinical Trial
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Oncology Clinical Trial
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies
Status: Enrolling,
Phase
I
Updated: 4/30/2018
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Status: Enrolling
Updated: 1/25/2012
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Status: Enrolling
Updated: 1/25/2012
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Status: Enrolling
Updated: 1/25/2012
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Status: Enrolling
Updated: 1/25/2012
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Status: Enrolling
Updated: 1/25/2012
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Status: Enrolling
Updated: 1/25/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Effects of Nocturnal Nasal Oxygen on Biomarkers in Sleep Apnea Patients With Heart Failure
Status: Enrolling
Updated: 5/11/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Effects of Nocturnal Nasal Oxygen on Biomarkers in Sleep Apnea Patients With Heart Failure
Status: Enrolling
Updated: 5/11/2012
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/17/2012
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/17/2012
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/17/2012
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/17/2012
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/17/2012
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/17/2012
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/17/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials
Hypoactive Sexual Desire Disorder Clinical Trial
Lybrido for Female Sexual Dysfunction
Status: Enrolling
Updated: 9/26/2011
Click here to add this to my saved trials
Hypoactive Sexual Desire Disorder Clinical Trial
Lybrido for Female Sexual Dysfunction
Status: Enrolling
Updated: 9/26/2011
Click here to add this to my saved trials
We've found
184,457
clinical trials
Children Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy Trial Clinical Trial
Updated: 4/9/2018
A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 6/18/2010
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
Status: Enrolling,
Phase
Updated: 6/18/2010
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
Longitudinal Study of Mitochondrial Hepatopathies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
Longitudinal Study of Mitochondrial Hepatopathies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 11/10/2011
RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 11/10/2011
Click here to add this to my saved trials
Reproductive Clinical Trial
Updated: 12/31/1969
A Prospective Natural History Study of Patients With Syringomyelia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Hereditary Hemorrhagic Telangiectasia Clinical Trial
Updated: 12/31/1969
Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hereditary Hemorrhagic Telangiectasia Clinical Trial
Updated: 12/31/1969
Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
131-I-MIBG Therapy for Refractory Neuroblastoma and Metastatic Paraganglioma/Pheochromocytoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials
Sinusitis Clinical Trial
Updated: 2/26/2016
Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children
Status: Enrolling
Updated: 2/26/2016
Click here to add this to my saved trials
Inflammatory Bowel Disease Clinical Trial
Updated: 12/31/1969
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Inflammatory Bowel Disease Clinical Trial
Updated: 12/31/1969
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/30/2012
Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Status: Enrolling,
Phase
II
Updated: 11/30/2012
Click here to add this to my saved trials
Leukemia Clinical Trial
Updated: 3/27/2018
Collection of Blood and/or Bone Marrow for Investigation and Characterization of Normal and Abnormal Cell Growth
Status: Enrolling,
Phase
Updated: 3/27/2018
Click here to add this to my saved trials
Liver Neoplasms Clinical Trial
Updated: 11/29/2012
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Status: Enrolling
Updated: 11/29/2012
Click here to add this to my saved trials
Aging Clinical Trial
Updated: 1/28/2016
Oxidative Stress Links Aging, Activity and Mobility Limitation
Status: Enrolling,
Phase
I
Updated: 1/28/2016
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 8/31/2012
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 8/31/2012
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 8/31/2012
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 8/31/2012
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 8/31/2012
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 8/31/2012
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Status: Enrolling
Updated: 8/31/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 7/31/2012
The OMEGA Clinical Trial
Status: Enrolling
Updated: 7/31/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 7/31/2012
The OMEGA Clinical Trial
Status: Enrolling
Updated: 7/31/2012
Click here to add this to my saved trials
Gastroenterology, Other, Reproductive Clinical Trial
Updated: 7/24/2013
Effect of Vitamin D Supplementation on In-vitro Fertilization (IVF) Outcomes
Status: Enrolling,
Phase
II
Updated: 7/24/2013
Click here to add this to my saved trials
Tetralogy of Fallot Clinical Trial
Updated: 10/5/2012
Assessment of Right Ventricular Volume in Tetralogy of Fallott (TOF) Patients
Status: Enrolling
Updated: 10/5/2012
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 8/26/2013
Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant
Status: Enrolling
Updated: 8/26/2013
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/3/2014
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 11/3/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/3/2014
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 11/3/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/3/2014
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 11/3/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/3/2014
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 11/3/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/3/2014
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 11/3/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/3/2014
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 11/3/2014
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Updated: 3/22/2013
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/22/2013
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Updated: 3/22/2013
Efficacy Study of Lu AA21004 on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/22/2013
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Updated: 1/19/2018
Effect of Metformin on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
Status: Enrolling
Updated: 1/19/2018
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Updated: 1/19/2018
Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
Status: Enrolling
Updated: 1/19/2018
Click here to add this to my saved trials
Infection Clinical Trial
Updated: 12/3/2015
Antibiotic Prophylaxis Before Percutaneous Gastrostomy
Status: Enrolling
Updated: 12/3/2015
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Brain Circuits in Schizophrenia and Smoking
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Rheumatology Clinical Trial
Updated: 12/31/1969
The Pathogenesis and Natural History of Sjogren s Syndrome
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/16/2015
Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)
Status: Enrolling,
Phase
III
Updated: 12/16/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/16/2015
Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)
Status: Enrolling,
Phase
III
Updated: 12/16/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/16/2015
Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)
Status: Enrolling,
Phase
III
Updated: 12/16/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/16/2015
Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)
Status: Enrolling,
Phase
III
Updated: 12/16/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/16/2015
Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)
Status: Enrolling,
Phase
III
Updated: 12/16/2015
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 7/1/2013
Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate
Status: Enrolling
Updated: 7/1/2013
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Updated: 12/2/2013
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling,
Phase
II
Updated: 12/2/2013
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Updated: 12/2/2013
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling,
Phase
II
Updated: 12/2/2013
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Updated: 12/2/2013
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling,
Phase
II
Updated: 12/2/2013
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Updated: 12/2/2013
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling,
Phase
II
Updated: 12/2/2013
Click here to add this to my saved trials
Hepatitis C Virus Clinical Trial
Updated: 12/2/2013
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Status: Enrolling,
Phase
II
Updated: 12/2/2013
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Updated: 12/9/2014
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Status: Enrolling,
Phase
III
Updated: 12/9/2014
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Updated: 12/9/2014
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Status: Enrolling,
Phase
III
Updated: 12/9/2014
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Updated: 12/9/2014
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Status: Enrolling,
Phase
III
Updated: 12/9/2014
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Updated: 12/9/2014
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Status: Enrolling,
Phase
III
Updated: 12/9/2014
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Updated: 12/9/2014
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Status: Enrolling,
Phase
III
Updated: 12/9/2014
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Updated: 12/9/2014
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Status: Enrolling,
Phase
III
Updated: 12/9/2014
Click here to add this to my saved trials
Ischemic Stroke Clinical Trial
Updated: 2/19/2014
Assess the Penumbra System in the Treatment of Acute Stroke
Status: Enrolling,
Phase
IV
Updated: 2/19/2014
Click here to add this to my saved trials
Ischemic Stroke Clinical Trial
Updated: 2/19/2014
Assess the Penumbra System in the Treatment of Acute Stroke
Status: Enrolling,
Phase
IV
Updated: 2/19/2014
Click here to add this to my saved trials
Other Clinical Trial
Updated: 4/18/2016
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Other Clinical Trial
Updated: 4/18/2016
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Other Clinical Trial
Updated: 4/18/2016
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Other Clinical Trial
Updated: 4/18/2016
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/30/2018
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies
Status: Enrolling,
Phase
I
Updated: 4/30/2018
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Updated: 1/25/2012
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Status: Enrolling
Updated: 1/25/2012
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Updated: 1/25/2012
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Status: Enrolling
Updated: 1/25/2012
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Updated: 1/25/2012
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Status: Enrolling
Updated: 1/25/2012
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Updated: 1/25/2012
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Status: Enrolling
Updated: 1/25/2012
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Updated: 1/25/2012
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Status: Enrolling
Updated: 1/25/2012
Click here to add this to my saved trials
Non-24-Hour Sleep-Wake Disorder Clinical Trial
Updated: 1/25/2012
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
Status: Enrolling
Updated: 1/25/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 5/11/2012
Effects of Nocturnal Nasal Oxygen on Biomarkers in Sleep Apnea Patients With Heart Failure
Status: Enrolling
Updated: 5/11/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 5/11/2012
Effects of Nocturnal Nasal Oxygen on Biomarkers in Sleep Apnea Patients With Heart Failure
Status: Enrolling
Updated: 5/11/2012
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Updated: 10/17/2012
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/17/2012
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Updated: 10/17/2012
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/17/2012
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Updated: 10/17/2012
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/17/2012
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Updated: 10/17/2012
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/17/2012
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Updated: 10/17/2012
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/17/2012
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Updated: 10/17/2012
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/17/2012
Click here to add this to my saved trials
Pulmonary Disease, Chronic Obstructive Clinical Trial
Updated: 10/17/2012
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/17/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 4/2/2018
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 4/2/2018
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 4/2/2018
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 4/2/2018
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 4/2/2018
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 4/2/2018
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials
Hypoactive Sexual Desire Disorder Clinical Trial
Updated: 9/26/2011
Lybrido for Female Sexual Dysfunction
Status: Enrolling
Updated: 9/26/2011
Click here to add this to my saved trials
Hypoactive Sexual Desire Disorder Clinical Trial
Updated: 9/26/2011
Lybrido for Female Sexual Dysfunction
Status: Enrolling
Updated: 9/26/2011
Click here to add this to my saved trials